Description: The SOA recently launched the Mortality and Longevity Strategic Research Program with the release of a new study on the economic impact of opioid abuse. In this session, results of this study will be presented along with insights and plans for the future of the Program.

Description: Breakout Sessions 1A: The Fundamentals of Pricing for Underwriters

Description: Dr Horvath's research lies at the intersection of aging research, epidemiology, chronic diseases, epigenetics, genetics, and systems biology. He works on all aspects of biomarker development with a particular focus on genomic biomarkers of aging. He developed a highly accurate multi-tissue biomarker of aging known as the epigenetic clock. Dr Horvath developed systems biologic approaches such as weighted gene co-expression network analysis which lend themselves for integrating gene genomic data sets. These methods have been used for a broad spectrum of age-related diseases including neurodegenerative diseases, cancer, cardiovascular disease. Dr. Horvath received a Ph.D. in Mathematics from the University of North Carolina, Chapel Hill in 1995 and a Doctorate of Science in Biostatistics from the Harvard School of Public Health in 2000.

Description: This the Application Tool for Mortality Improvement Model, MIM-2021.

Description: Papers: Chronic Diseases and Longevity Risk: An Application to Type II Diabetes Insurance Products – Hsin-Chung Wang, Ph.D. - Aletheia University; Jack C. Yue, ASA, Ph.D. – National Chengchi University; Ting-Chung Chang - Chihlee University of Technology Understanding Multimorbidities - Sam Gutterman, FSA, CERA, FCA, FCAS, HONFIA, MAAA

Description: This is the user guide for the Mortality Improvement Model, MIM-2021, Data Analysis Tool

Description: This is the user guide for the Mortality Improvement Model, MIM-2021, Data Analysis Tool

Description: Feature article discussing the events of the recent Living to 100 Symposium.